Our findings regarding the association of high pMLKL and high PD-L1 and a clinically favorable OS in CCA patients therefore provided the first clinical relevance in human cancer patients and supported a recent study proposing the use of checkpoint blockade immunotherapy in cancer and CCA patients with an inflamed subtype7,69. Here, CD274 is linked to cancer.